Point72 Asset Management
EBS icon

Point72 Asset Management’s Emergent Biosolutions EBS Stock Holding History

Point72 Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-44,779
Closed -$152K – 2316
2023
Q3 		$152K Buy
+44,779
New +$248K ﹤0.01% 1843
2021
Q1 		– Sell
-55,661
Closed -$4.99M – 1012
2020
Q4 		$4.99M Buy
+55,661
New +$5.11M 0.02% 583
2019
Q4 		– Sell
-2,500
Closed -$131K – 1029
2019
Q3 		$131K Buy
2,500
+2,200
+733% +$102K ﹤0.01% 950
2019
Q2 		$14K Buy
+300
New +$14.4K ﹤0.01% 1267

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management's EBS Position: Q4 2023 in Review

Point72 Asset Management sold out of Emergent Biosolutions (EBS) in Q4 2023, closing a stake of 44,779 shares — an estimated $152K sold.

Point72 Asset Management first reported a position in EBS in Q2 2019 and held it in 4 quarters. The position peaked at $4.99M in Q4 2020. 134 funds tracked by Wall St. Rank hold EBS as of Q4 2023.

  • Point72 Asset Management reported no remaining Emergent Biosolutions position as of Q4 2023 after selling out during the quarter.
  • Point72 Asset Management sold 44,779 Emergent Biosolutions shares in Q4 2023, an estimated $152K.
  • Point72 Asset Management first reported a position in Emergent Biosolutions in Q2 2019 and held it in 4 quarters.
  • Point72 Asset Management's Emergent Biosolutions position peaked at $4.99M in Q4 2020.
  • 134 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.